Transgend Health. 2024 Dec 16;9(6):516-521. doi: 10.1089/trgh.2022.0087. eCollection 2024 Dec.
ABSTRACT
PURPOSE: This study describes Thai transfeminine individuals’ exogenous hormone use.
METHODS: During the period May-July 2017, a survey was conducted among Thai transfeminine adults (N=181) who reported their exogenous hormone use, age at onset of use, brands used, where they obtained hormones, and discontinuation of use.
RESULTS: Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%).
CONCLUSIONS: Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.
PMID:39735376 | PMC:PMC11669632 | DOI:10.1089/trgh.2022.0087
